1-20 of 27
Nancy E. Davidson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Long and Winding Road for Breast Cancer Biomarkers to Reach Clinical Utility

Natasha B. Hunter, Mark R. Kilgore, Nancy E. Davidson
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (21): 5543–5545.
https://doi.org/10.1158/1078-0432.CCR-20-2451
Published: 02 November 2020
View articletitled, The Long and Winding Road for Breast Cancer Biomarkers to Reach Clinical Utility
Open the PDF for The Long and Winding Road for Breast Cancer Biomarkers to Reach Clinical Utility in another window
Journal Articles

Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

Roisin M. Connolly, Huili Li, Rachel C. Jankowitz, Zhe Zhang, Michelle A. Rudek, Stacie C. Jeter, Shannon A. Slater, Penny Powers, Antonio C. Wolff, John H. Fetting, Adam Brufsky, Richard Piekarz, Nita Ahuja, Peter W. Laird, Hui Shen, Daniel J. Weisenberger, Leslie Cope, James G. Herman, George Somlo, Agustin A. Garcia, Peter A. Jones, Stephen B. Baylin, Nancy E. Davidson, Cynthia A. Zahnow, Vered Stearns
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11): 2691–2701.
https://doi.org/10.1158/1078-0432.CCR-16-1729
Published: 31 May 2017
View articletitled, Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
Open the PDF for Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study in another window
Includes: Supplementary data
Journal Articles

New Strategies in Metastatic Hormone Receptor–Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted Therapies

Rachel C. Jankowitz, Steffi Oesterreich, Adrian V. Lee, Nancy E. Davidson
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (5): 1126–1131.
https://doi.org/10.1158/1078-0432.CCR-16-0591
Published: 28 February 2017
View articletitled, New Strategies in Metastatic Hormone Receptor–Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted Therapies
Open the PDF for New Strategies in Metastatic Hormone Receptor–Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted Therapies in another window
Journal Articles

Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure

Bryan P. Schneider, Fei Shen, Laura Gardner, Milan Radovich, Lang Li, Kathy D. Miller, Guanglong Jiang, Dongbing Lai, Anne O'Neill, Joseph A. Sparano, Nancy E. Davidson, David Cameron, Irmina Gradus-Pizlo, Ronald A. Mastouri, Thomas M. Suter, Tatiana Foroud, George W. Sledge, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (1): 43–51.
https://doi.org/10.1158/1078-0432.CCR-16-0908
Published: 02 January 2017
View articletitled, Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure
Open the PDF for Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure in another window
Includes: Supplementary data
Journal Articles

Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer

Rekha Gyanchandani, Yan Lin, Hui-Min Lin, Kristine Cooper, Daniel P. Normolle, Adam Brufsky, Michael Fastuca, Whitney Crosson, Steffi Oesterreich, Nancy E. Davidson, Rohit Bhargava, David J. Dabbs, Adrian V. Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (21): 5362–5369.
https://doi.org/10.1158/1078-0432.CCR-15-2889
Published: 31 October 2016
View articletitled, Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer
Open the PDF for Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Multiparametric Genomic Assays for Breast Cancer: Time for the Next Generation?

Adam M. Brufsky, Nancy E. Davidson
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (20): 4963–4965.
https://doi.org/10.1158/1078-0432.CCR-16-1513
Published: 13 October 2016
View articletitled, Multiparametric Genomic Assays for Breast Cancer: Time for the Next Generation?
Open the PDF for Multiparametric Genomic Assays for Breast Cancer: Time for the Next Generation? in another window
Journal Articles

AACR Cancer Progress Report 2016

Nancy E. Davidson, Scott A. Armstrong, Lisa M. Coussens, Marcia R. Cruz-Correa, Ralph J. DeBerardinis, James H. Doroshow, Margaret Foti, Patrick Hwu, Thomas W. Kensler, Monica Morrow, Charles G. Mulligan, William Pao, Elizabeth A. Platz, Thomas J. Smith, Cheryl L. Willman
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (19_Supplement): S1–S137.
https://doi.org/10.1158/1078-0432.CCR-16-1993
Published: 02 October 2016
View articletitled, AACR Cancer Progress Report 2016
Open the PDF for AACR Cancer Progress Report 2016 in another window
Journal Articles

Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients

Peilu Wang, Amir Bahreini, Rekha Gyanchandani, Peter C. Lucas, Ryan J. Hartmaier, Rebecca J. Watters, Amruth R. Jonnalagadda, Humberto E. Trejo Bittar, Aaron Berg, Ronald L. Hamilton, Brenda F. Kurland, Kurt R. Weiss, Aju Mathew, Jose Pablo Leone, Nancy E. Davidson, Marina N. Nikiforova, Adam M. Brufsky, Tadeu F. Ambros, Andrew M. Stern, Shannon L. Puhalla, Adrian V. Lee, Steffi Oesterreich
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (5): 1130–1137.
https://doi.org/10.1158/1078-0432.CCR-15-1534
Published: 29 February 2016
View articletitled, Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
Open the PDF for Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

Bryan P. Schneider, Lang Li, Milan Radovich, Fei Shen, Kathy D. Miller, David A. Flockhart, Guanglong Jiang, Gail Vance, Laura Gardner, Matteo Vatta, Shaochun Bai, Dongbing Lai, Daniel Koller, Fengmin Zhao, Anne O'Neill, Mary Lou Smith, Elda Railey, Carol White, Ann Partridge, Joseph Sparano, Nancy E. Davidson, Tatiana Foroud, George W. Sledge, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (22): 5082–5091.
https://doi.org/10.1158/1078-0432.CCR-15-0586
Published: 12 November 2015
View articletitled, Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199
Open the PDF for Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199 in another window
Includes: Supplementary data
Journal Articles

Can Circulating Tumor Cells Predict Resistance in Metastatic Breast Cancer?

Aju Mathew, Adam M. Brufsky, Nancy E. Davidson
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (11): 2421–2423.
https://doi.org/10.1158/1078-0432.CCR-14-2967
Published: 31 May 2015
View articletitled, Can Circulating Tumor Cells Predict Resistance in Metastatic Breast Cancer?
Open the PDF for Can Circulating Tumor Cells Predict Resistance in Metastatic Breast Cancer? in another window
Journal Articles

Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831

Amylou C. Dueck, Monica M. Reinholz, Xochiquetzal J. Geiger, Kathleen Tenner, Karla Ballman, Robert B. Jenkins, Darren Riehle, Beiyun Chen, Ann E. McCullough, Nancy E. Davidson, Silvana Martino, George W. Sledge, Peter A. Kaufman, Leila A. Kutteh, Julie Gralow, Lyndsay N. Harris, James N. Ingle, Wilma L. Lingle, Edith A. Perez
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (20): 5798–5807.
https://doi.org/10.1158/1078-0432.CCR-13-0558
Published: 14 October 2013
View articletitled, Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831
Open the PDF for Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831 in another window
Includes: Supplementary data
Journal Articles

Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer

Vered Stearns, Lisa K. Jacobs, MaryJo Fackler, Theodore N. Tsangaris, Michelle A. Rudek, Michaela Higgins, Julie Lange, Zandra Cheng, Shannon A. Slater, Stacie C. Jeter, Penny Powers, Susanne Briest, Calvin Chao, Carl Yoshizawa, Elizabeth Sugar, Igor Espinoza-Delgado, Saraswati Sukumar, Edward Gabrielson, Nancy E. Davidson
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (14): 4008–4016.
https://doi.org/10.1158/1078-0432.CCR-13-0033
Published: 15 July 2013
View articletitled, Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer
Open the PDF for Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial

Bryan P. Schneider, Robert J. Gray, Milan Radovich, Fei Shen, Gail Vance, Lang Li, Guanglong Jiang, Kathy D. Miller, Julie R. Gralow, Maura N. Dickler, Melody A. Cobleigh, Edith A. Perez, Tamara N. Shenkier, Kirsten Vang Nielsen, Sven Müller, Ann Thor, George W. Sledge, Jr, Joseph A. Sparano, Nancy E. Davidson, Sunil S. Badve
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (5): 1281–1289.
https://doi.org/10.1158/1078-0432.CCR-12-3029
Published: 03 March 2013
View articletitled, Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial
Open the PDF for Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial in another window
Includes: Supplementary data
Journal Articles

Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer

Joseph A. Sparano, Lori J. Goldstein, Barrett H. Childs, Steven Shak, Diana Brassard, Sunil Badve, Frederick L. Baehner, Roberto Bugarini, Steve Rowley, Edith A. Perez, Lawrence N. Shulman, Silvana Martino, Nancy E. Davidson, Paraic A. Kenny, George W. Sledge, Jr, Robert Gray
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (22): 7194–7203.
https://doi.org/10.1158/1078-0432.CCR-10-3357
Published: 14 November 2011
View articletitled, Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer
Open the PDF for Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer

Joseph A. Sparano, Lori J. Goldstein, Barrett H. Childs, Steven Shak, Diana Brassard, Sunil Badve, Frederick L. Baehner, Roberto Bugarini, Steve Rowley, Edith Perez, Lawrence N. Shulman, Silvana Martino, Nancy E. Davidson, George W. Sledge, Jr., Robert Gray
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (24): 7693–7700.
https://doi.org/10.1158/1078-0432.CCR-09-1450
Published: 14 December 2009
View articletitled, Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer
Open the PDF for Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer in another window
Includes: Supplementary data
Journal Articles

A Phase I-II Study of Combined Blockade of the ErbB Receptor Network with Trastuzumab and Gefitinib in Patients with HER2 (ErbB2)-Overexpressing Metastatic Breast Cancer

Carlos L. Arteaga, Anne O'Neill, Stacy L. Moulder, Michael Pins, Joseph A. Sparano, George W. Sledge, Nancy E. Davidson
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (19): 6277–6283.
https://doi.org/10.1158/1078-0432.CCR-08-0482
Published: 30 September 2008
View articletitled, A Phase I-II Study of Combined Blockade of the ErbB Receptor Network with Trastuzumab and Gefitinib in Patients with HER2 (ErbB2)-Overexpressing Metastatic Breast Cancer
Open the PDF for A Phase I-II Study of Combined Blockade of the ErbB Receptor Network with Trastuzumab and Gefitinib in Patients with HER2 (ErbB2)-Overexpressing Metastatic Breast Cancer in another window
Journal Articles

Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases

Julie M. Wu, Mary Jo Fackler, Marc K. Halushka, Diana W. Molavi, M. Evangeline Taylor, Wei Wen Teo, Constance Griffin, John Fetting, Nancy E. Davidson, Angelo M. De Marzo, Jessica L. Hicks, Dhananjay Chitale, Marc Ladanyi, Saraswati Sukumar, Pedram Argani
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (7): 1938–1946.
https://doi.org/10.1158/1078-0432.CCR-07-4082
Published: 01 April 2008
View articletitled, Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases
Open the PDF for Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases in another window
Includes: Supplementary data
Journal Articles

Epigenetic Biomarkers and Breast Cancer: Cause for Optimism

Kala Visvanathan, Saraswati Sukumar, Nancy E. Davidson
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (22): 6591–6593.
https://doi.org/10.1158/1078-0432.CCR-06-2001
Published: 22 November 2006
View articletitled, Epigenetic Biomarkers and Breast Cancer: Cause for Optimism
Open the PDF for Epigenetic Biomarkers and Breast Cancer: Cause for Optimism in another window
Journal Articles

Quantitative Multiplex Methylation-Specific PCR Analysis Doubles Detection of Tumor Cells in Breast Ductal Fluid

Mary Jo Fackler, Kara Malone, Zhe Zhang, Eric Schilling, Elizabeth Garrett-Mayer, Theresa Swift-Scanlan, Julie Lange, Ritu Nayar, Nancy E. Davidson, Seema A. Khan, Saraswati Sukumar
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (11): 3306–3310.
https://doi.org/10.1158/1078-0432.CCR-05-2733
Published: 01 June 2006
View articletitled, Quantitative Multiplex Methylation-Specific PCR Analysis Doubles Detection of Tumor Cells in Breast Ductal Fluid
Open the PDF for Quantitative Multiplex Methylation-Specific PCR Analysis Doubles Detection of Tumor Cells in Breast Ductal Fluid in another window
Journal Articles

A Phase II Study of the Polyamine Analog N 1, N 11-Diethylnorspermine (DENSpm) Daily for Five Days Every 21 Days in Patients with Previously Treated Metastatic Breast Cancer

Antonio C. Wolff, Deborah K. Armstrong, John H. Fetting, M. Katherine Carducci, Carol D. Riley, John F. Bender, Robert A. Casero, Jr., Nancy E. Davidson
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5922–5928.
Published: 15 December 2003
View articletitled, A Phase II Study of the Polyamine Analog N 1, N 11-Diethylnorspermine (DENSpm) Daily for Five Days Every 21 Days in Patients with Previously Treated Metastatic Breast Cancer
Open the PDF for A Phase II Study of the Polyamine Analog N 1, N 11-Diethylnorspermine (DENSpm) Daily for Five Days Every 21 Days in Patients with Previously Treated Metastatic Breast Cancer in another window